AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

HARROW, INC. Director's Dealing 2018

Nov 13, 2018

31774_dirs_2018-11-13_c752c1a8-befa-406e-b444-23522afd387f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2018-11-09

Reporting Person: Imprimis Pharmaceuticals, Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500000	Direct